Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients-Reference-Cited by-同舟云学术

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients

Published:2009-02 Issue:3 Volume:45 Page:478-489
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Gutwein Paul,Schramme Anja,Sinke Nina,Abdel-Bakky Mohamed Sadek,Voss Beren,Obermüller Nicholas,Doberstein Kai,Koziolek Michael,Fritzsche Florian,Johannsen Manfred,Jung Klaus,Schaider Helmut,Altevogt Peter,Ludwig Andreas,Pfeilschifter Josef,Kristiansen Glen

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Renal cell carcinoma: current status and future prospects;Drucker;Cancer Treat Rev,2005

2. The changing natural history of renal cell carcinoma;Pantuck;J Urol,2001

3. Chemokines in tumor progression and metastasis;Tanaka;Cancer Sci,2005

4. Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector;Gao;Biol Pharm Bull,2005

5. SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10;Sharma;Mol Cancer,2003

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multidimensional comprehensive and integrated analysis of the potential function of TMEM25 in renal clear cell carcinoma with low expression status;Aging;2024-01-05

2. How chemokines organize the tumour microenvironment;Nature Reviews Cancer;2023-12-08

3. Chromosome 17;Cancer Genes: Volume 2;2023-08-16

4. Role of the CXCR6/CXCL16 axis in autoimmune diseases;International Immunopharmacology;2023-08

5. Osteoid cell-derived chemokines drive bone-metastatic prostate cancer;Frontiers in Oncology;2023-03-21